| CEUAX | TIOHX | CEUAX / TIOHX | |
| Total Expense Ratio | 0.86 | 0.68 | 126% |
| Annual Report Gross Expense Ratio | 0.86 | 0.68 | 126% |
| Fund Existence | 25 years | 11 years | - |
| Gain YTD | 5.423 | 7.748 | 70% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 100000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 140B | 2.61B | 5,364% |
| Annual Yield % from dividends | 2.52 | 1.85 | 136% |
| Returns for 1 year | 2.04 | 4.42 | 46% |
| Returns for 3 years | 27.28 | 34.67 | 79% |
| Returns for 5 years | -4.19 | -6.58 | 64% |
| Returns for 10 years | 51.84 | 87.76 | 59% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FACGX | 185.57 | 1.03 | +0.56% |
| Fidelity Advisor Growth Opps C | |||
| HIBCX | 52.18 | 0.13 | +0.25% |
| Hartford Capital Appreciation HLS IB | |||
| RYVFX | 11.69 | -0.06 | -0.51% |
| Royce Small-Cap Value Service | |||
| HFCSX | 34.31 | -0.19 | -0.55% |
| Hennessy Focus Investor | |||
| FBTDX | 170.40 | -3.12 | -1.80% |
| Franklin Biotechnology Discovery C | |||